Literature DB >> 1576286

Catheter-associated sepsis caused by Ochrobactrum anthropi: report of a case and review of related nonfermentative bacteria.

T J Cieslak1, M L Robb, C J Drabick, G W Fischer.   

Abstract

Ochrobactrum anthropi, formerly known as CDC group Vd, is an oxidase-producing, gram-negative, non-lactose-fermenting bacillus that oxidizes glucose and grows readily on MacConkey agar. Only occasionally isolated from human clinical specimens, this organism has rarely been found to be pathogenic. We describe the first reported case of infection due to O. anthropi in a child, that of bacteremia in a 3-year-old girl undergoing chemotherapy for retinoblastoma. In addition, we review the literature concerning cases of infection due to this and closely related bacterial species, namely Alcaligenes xylosoxidans subspecies xylosoxidans, Agrobacterium radiobacter, and "Achromobacter" group B. Finally, we attempt to clarify the confusing history and taxonomy of these organisms as well as make recommendations regarding antimicrobial therapy for infections caused by them.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1576286     DOI: 10.1093/clinids/14.4.902

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  26 in total

1.  Ochrobactrum anthropi misidentified as Shewanella putrefaciens.

Authors:  Jeffrey W Oliver
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

2.  Meningitis caused by Alcaligenes (Achromobacter) xylosoxidans associated with epidural catheter.

Authors:  J M Ramos; R Fernández-Roblas; P García-Ruiz; F Soriano
Journal:  Infection       Date:  1995 Nov-Dec       Impact factor: 3.553

3.  Septic shock caused by Ochrobactrum anthropi in an otherwise healthy host.

Authors:  Adrien Kettaneh; François-Xavier Weill; Isabelle Poilane; Olivier Fain; Michel Thomas; Jean-Louis Herrmann; Laurent Hocqueloux
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

4.  Antibody and delayed-type hypersensitivity responses to Ochrobactrum anthropi cytosolic and outer membrane antigens in infections by smooth and rough Brucella spp.

Authors:  J Velasco; R Díaz; M J Grilló; M Barberán; C Marín; J M Blasco; I Moriyón
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

5.  Bacteremia caused by Ochrobactrum anthropi in an immunocompromised child.

Authors:  M Haditsch; L Binder; G Tschurtschenthaler; R Watschinger; G Zauner; H Mittermayer
Journal:  Infection       Date:  1994 Jul-Aug       Impact factor: 3.553

6.  An opportunistic pathogen in a peritoneal dialysis patient: Ochrobactrum anthropi.

Authors:  Caner Alparslan; Onder Yavascan; Engin Kose; Pinar Sanlioglu; Nejat Aksu
Journal:  Indian J Pediatr       Date:  2012-06-10       Impact factor: 1.967

Review 7.  Prosthetic mitral valve endocarditis due to Ochrobactrum anthropi: case report.

Authors:  M P Romero Gómez; A M Peinado Esteban; J A Sobrino Daza; J A Sáez Nieto; D Alvarez; P Peña García
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

Review 8.  Ochrobactrum anthropi bacteremia: report of four cases and short review.

Authors:  W V Kern; M Oethinger; A Kaufhold; E Rozdzinski; R Marre
Journal:  Infection       Date:  1993 Sep-Oct       Impact factor: 3.553

Review 9.  Brucellosis: an overview.

Authors:  M J Corbel
Journal:  Emerg Infect Dis       Date:  1997 Apr-Jun       Impact factor: 6.883

10.  Ochrobactrum intermedium infection after liver transplantation.

Authors:  L V Möller; J P Arends; H J Harmsen; A Talens; P Terpstra; M J Slooff
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.